中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2014年
2期
221-223
,共3页
奥美拉唑%左氧氟沙星%甲硝唑%慢性胃炎
奧美拉唑%左氧氟沙星%甲硝唑%慢性胃炎
오미랍서%좌양불사성%갑초서%만성위염
Omeprazole%Left-Ofloxacin%Metronidazole%Chronic gastritis
目的 探究奥美拉唑、左氧氟沙星和甲硝唑联合治疗幽门螺杆菌(Hp)所致慢性胃炎的临床疗效.方法 以100例慢性胃炎患者为研究对象,按照随机数字表法分为观察组和对照组,每组50例.观察组接受奥美拉唑、左氧氟沙星和甲硝唑三联法治疗,对照组只接受奥美拉唑治疗.结果 观察组总有效率(94％)显著高于对照组(82％)(x2=7.37,P＜0.05).观察组Hp转阴率90％,对照组为72％,观察组抑制Hp效果优于对照组(x2 =8.12,P＜0.05).结论 采用奥美拉唑、左氧氟沙星和甲硝唑治疗Hp优于单用奥美拉唑,疗效显著,不良反应少、安全.
目的 探究奧美拉唑、左氧氟沙星和甲硝唑聯閤治療幽門螺桿菌(Hp)所緻慢性胃炎的臨床療效.方法 以100例慢性胃炎患者為研究對象,按照隨機數字錶法分為觀察組和對照組,每組50例.觀察組接受奧美拉唑、左氧氟沙星和甲硝唑三聯法治療,對照組隻接受奧美拉唑治療.結果 觀察組總有效率(94％)顯著高于對照組(82％)(x2=7.37,P＜0.05).觀察組Hp轉陰率90％,對照組為72％,觀察組抑製Hp效果優于對照組(x2 =8.12,P＜0.05).結論 採用奧美拉唑、左氧氟沙星和甲硝唑治療Hp優于單用奧美拉唑,療效顯著,不良反應少、安全.
목적 탐구오미랍서、좌양불사성화갑초서연합치료유문라간균(Hp)소치만성위염적림상료효.방법 이100례만성위염환자위연구대상,안조수궤수자표법분위관찰조화대조조,매조50례.관찰조접수오미랍서、좌양불사성화갑초서삼련법치료,대조조지접수오미랍서치료.결과 관찰조총유효솔(94％)현저고우대조조(82％)(x2=7.37,P＜0.05).관찰조Hp전음솔90％,대조조위72％,관찰조억제Hp효과우우대조조(x2 =8.12,P＜0.05).결론 채용오미랍서、좌양불사성화갑초서치료Hp우우단용오미랍서,료효현저,불량반응소、안전.
Objective To explore the clinical efficacy of omeprazole,levofloxacin and metronidazole in the treatment of chronic gastritis caused by Helicobacter pylori.Methods 100 patients with chronic gastritis were selected as the research subjects.In accordance with digital table method,100 patients were randomly divided into the observation group and control group.Each group had 50 patients.The observation group was given triple therapy with omeprazole,levofloxacin and metronidasole.The control group was only given omeprazole.Results The total effective rate of the observation group was 94％,which was significantly higher than 82％ of the control group (x2 =7.37,P ＜ 0.05).The negative rate of Hp in observation group was 90％,which was significantly higher than 72％ of the control group (x2 =8.12,P ＜ 0.05).Conclusion The clinical efficacy of triple therapy of omeprazole,levofloxacin and metronidazole was better than the single therapy of omeprazole,which has significant effect,less adverse reactions.
